论文部分内容阅读
目的观察注射用炎琥宁联合重组干扰素喷雾剂治疗小儿手足口病的临床效果。方法研究对象为医院收治的符合诊断标准的手足口病患儿109例,随机分为观察组55例和对照组54例。对照组采用注射用炎琥宁治疗,观察组采用注射用炎琥宁联合重组干扰素喷雾剂治疗,观察比较2组的临床治疗效果。结果观察组治疗总有效率为89.09%,高于对照组的74.07%,差异有统计学意义(P<0.05)。结论注射用炎琥宁联合重组干扰素喷雾剂治疗小儿手足口病的临床效果显著,值得推广应用。
Objective To observe the clinical efficacy of injection of mesylate combined with recombinant interferon in the treatment of children hand-foot-mouth disease. Methods A total of 109 children with hand-foot-mouth disease who met the diagnostic criteria were randomly divided into observation group (55 cases) and control group (54 cases). The control group was treated with injection of mesylate, and the observation group was treated with injection of mesylate combined with recombinant interferon. The clinical effects of the two groups were observed and compared. Results The total effective rate of observation group was 89.09%, which was higher than that of control group (74.07%), the difference was statistically significant (P <0.05). Conclusion Injection of Yan Hu Ning combined with recombinant interferon spray treatment of children with hand-foot-mouth disease clinical effect is significant, it is worth promoting the application.